Showing results (41-50 of 195) with videos related to
Sort By:
Pageof 20
Kidney and Dialysis|November 16, 2022
The Pathophysiological Basis of Diabetic Kidney Protection by Inhibition of SGLT2 and SGLT1Yuji Oe, Volker VallonCurrent Opinion in Nephrology and Hypertension|July 18, 2018
Renal tubular solute transport and oxygen consumption: insights from computational modelsAnita T Layton, Volker VallonCurrent Diabetes Reports|April 15, 2018
Renal Effects of Incretin-Based Diabetes Therapies: Pre-clinical Predictions and Clinical Trial OutcomesScott C Thomson, Volker VallonExperimental Physiology|August 3, 2014
Intestinal regulation of urinary sodium excretion and the pathophysiology of diabetic kidney disease: a focus on glucagon-like peptide 1 and dipeptidyl peptidase 4Volker Vallon, Neil G DochertyKidney & Blood Pressure Research|November 19, 2002
Protein kinase C beta isoenzymes in diabetic kidneys and their relation to nephroprotective actions of the ACE inhibitor lisinoprilImke L Pfaff, Volker VallonAmerican Journal of Physiology. Renal Physiology|March 1, 2021
Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic ratsScott Culver Thomson, Volker VallonAmerican Journal of Physiology. Renal Physiology|January 25, 2018
SGLT2 inhibition in a kidney with reduced nephron number: modeling and analysis of solute transport and metabolismAnita T Layton, Volker VallonThe American Journal of Cardiology|November 20, 2019
Renal Effects of Sodium-Glucose Co-Transporter InhibitorsScott C Thomson, Volker VallonNature Reviews. Nephrology|March 11, 2020
The tubular hypothesis of nephron filtration and diabetic kidney diseaseVolker Vallon, Scott C ThomsonDiabetologia|November 24, 2016
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibitionVolker Vallon, Scott C ThomsonPageof 20